<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: crohn s disease</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Parasitologist espouses using parasitic worms for treatment of autoimmune diseases</title>
   	 <description>(Medical Xpress)—Doctor Joel Weinstock, a parasitologist at Tufts Medical Center in a commentary piece published in the journal Nature, describes work that he and colleagues have been involved in that focuses on studying the possibility of introducing parasitic worms into the guts of patients suffering from autoimmune diseases such as Crohn's disease. The thinking he says, is that modern hygienic lifestyles may be contributing to such diseases and that reintroducing parasitic worms and perhaps certain bacteria into the gut may restore a natural balance in the gut and relieve patients of such symptoms as chronic diarrhea, bleeding and infections.</description>
     <link>http://medicalxpress.com/news/2012-11-parasitologist-espouses-parasitic-worms-treatment.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 08 Nov 2012 06:00:01 EST</pubDate>
	 <guid isPermaLink="false">news271574652</guid>
	 
</item>
<item>
     <title>Genetically engineered bacteria could help in Crohn's and colitis</title>
   	 <description>(Medical Xpress)—A new study in mice has shown that genetically engineered bacteria can protect against inflammatory bowel disease (IBD), which includes a host of conditions including ulcerative colitis and Crohn's disease.</description>
     <link>http://medicalxpress.com/news/2012-11-genetically-bacteria-crohn-colitis.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 02 Nov 2012 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news271050191</guid>
	 
</item>
<item>
     <title>Specific bacterial species may initiate, maintain Crohn's</title>
   	 <description>Patients newly diagnosed with pediatric Crohn's disease had significantly different levels of certain types of bacteria in their intestinal tracts than age-matched controls, according to a paper in the October Journal of Clinical Microbiology. The work may ultimately lead to treatment involving manipulation of the intestinal bacteria.</description>
     <link>http://medicalxpress.com/news/2012-10-specific-bacterial-species-crohn.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 22 Oct 2012 14:32:13 EST</pubDate>
	 <guid isPermaLink="false">news270135115</guid>
	 
</item>
<item>
     <title>Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies</title>
   	 <description>Teamwork between a pair of transcription factors may be responsible for regulating the functioning of Th17 cells, which when found in excessive amounts are believed to play a major role in many autoimmune diseases, according to a study published last week in the journal Science by a national team of researchers.</description>
     <link>http://medicalxpress.com/news/2012-09-molecular-pathways-involved-autoimmune-diseases.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 28 Sep 2012 08:26:12 EST</pubDate>
	 <guid isPermaLink="false">news268039560</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/escalante-science-2012.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers determine how inflammatory cells function, setting stage for future remedies</title>
   	 <description>A research team led by investigators at New York University and NYU School of Medicine has determined how cells that cause inflammatory ailments, such as Crohn's disease, multiple sclerosis, and arthritis, differentiate from stem cells and ultimately affect the clinical outcome of these diseases.</description>
     <link>http://medicalxpress.com/news/2012-09-inflammatory-cells-function-stage-future.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Wed, 26 Sep 2012 13:24:34 EST</pubDate>
	 <guid isPermaLink="false">news267884658</guid>
	 
</item>
<item>
     <title>Bone marrow holds secrets for treating colitis and Crohn's</title>
   	 <description>(Medical Xpress)—Michigan State University researchers have unlocked secrets in bone marrow that could lead to improved treatments for colitis and Crohn's disease.</description>
     <link>http://medicalxpress.com/news/2012-09-bone-marrow-secrets-colitis-crohn.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 24 Sep 2012 16:37:01 EST</pubDate>
	 <guid isPermaLink="false">news267723389</guid>
	 
</item>
<item>
     <title>Antibiotics in childhood may increase bowel disease risk: study</title>
   	 <description>(HealthDay)—Use of certain antibiotics may put children at higher risk for developing bowel diseases, new research has found.</description>
     <link>http://medicalxpress.com/news/2012-09-antibiotics-childhood-bowel-disease.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Mon, 24 Sep 2012 11:59:08 EST</pubDate>
	 <guid isPermaLink="false">news267706740</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/antibioticsi.jpg" width="90" height="90" />
</item>
<item>
     <title>Research suggests promise of cell therapy for bowel disease</title>
   	 <description> New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the intestine and contribute to the cell population there, suggesting the cells' potential to treat inflammatory bowel disease (IBD).</description>
     <link>http://medicalxpress.com/news/2012-09-cell-therapy-bowel-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 19 Sep 2012 15:53:24 EST</pubDate>
	 <guid isPermaLink="false">news267288796</guid>
	 
</item>
<item>
     <title>Study links sinusitis to microbial diversity, suggests new approach for dealing with common ailment</title>
   	 <description>A common bacteria ever-present on the human skin and previously considered harmless, may, in fact, be the culprit behind chronic sinusitis, a painful, recurring swelling of the sinuses that strikes more than one in ten Americans each year, according to a study by scientists at the University of California, San Francisco.</description>
     <link>http://medicalxpress.com/news/2012-09-links-sinusitis-microbial-diversity-approach.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 12 Sep 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news266675084</guid>
	 
</item>
<item>
     <title>Genes carried by E. coli bacteria linked to colon cancer</title>
   	 <description>What if a key factor ultimately behind a cancer was not a genetic defect but ecological?</description>
     <link>http://medicalxpress.com/news/2012-08-genes-coli-bacteria-linked-colon.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Aug 2012 14:00:10 EST</pubDate>
	 <guid isPermaLink="false">news264343202</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/escherichiac.jpg" width="90" height="90" />
</item>
<item>
     <title>Adalimumab is a promising therapy for children with Crohn's disease</title>
   	 <description>Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.</description>
     <link>http://medicalxpress.com/news/2012-08-adalimumab-therapy-children-crohn-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 06 Aug 2012 12:40:14 EST</pubDate>
	 <guid isPermaLink="false">news263475592</guid>
	 
</item>
<item>
     <title>Why belly fat isn't all bad: Fatty membrane helps regulate immune system</title>
   	 <description>A fatty membrane in the belly called the omentum has until recently been considered somewhat like the appendix -- it didn't seem to serve much purpose.</description>
     <link>http://medicalxpress.com/news/2012-06-belly-fat-isnt-bad-fatty.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 06 Jun 2012 17:00:32 EST</pubDate>
	 <guid isPermaLink="false">news258217448</guid>
	 
</item>
<item>
     <title>Routine care for Crohn's disease in children should include measurement of bone age</title>
   	 <description>(Medical Xpress) -- Measuring bone age should be a standard practice of care for pediatric patients with Crohn&amp;#146;s disease, in order to properly interpret growth status and improve treatment, according to a new study from the UCSF Benioff Children&amp;#146;s Hospital. &amp;#160;</description>
     <link>http://medicalxpress.com/news/2012-05-routine-crohn-disease-children-bone.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Fri, 25 May 2012 08:17:53 EST</pubDate>
	 <guid isPermaLink="false">news257152654</guid>
	 
</item>
<item>
     <title>Could compound in artificial sweeteners worsen Crohn's disease?</title>
   	 <description>(HealthDay) -- The food additive maltodextrin, commonly used in some artificial sweeteners, may worsen Crohn's disease by encouraging the growth of E. coli bacteria in the small intestine, a new study suggests.</description>
     <link>http://medicalxpress.com/news/2012-05-compound-artificial-sweeteners-worsen-crohn.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 21 May 2012 15:40:01 EST</pubDate>
	 <guid isPermaLink="false">news256829921</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/couldcompoun.jpg" width="90" height="90" />
</item>
<item>
     <title>Early introduction of biologic therapy improves Crohn's disease outcomes</title>
   	 <description>A large-scale study of medical claims data shows that introducing sophisticated biologic therapies early in the course of treatment for Crohn's disease improves response to medication and reduces the need for surgery.</description>
     <link>http://medicalxpress.com/news/2012-04-early-introduction-biologic-therapy-crohn.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Tue, 17 Apr 2012 13:14:32 EST</pubDate>
	 <guid isPermaLink="false">news253887260</guid>
	 
</item>
<item>
     <title>Research provides new hope for those suffering from Crohn's disease</title>
   	 <description>Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to Crohn's disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). This research is a major milestone in developing future drug therapies for those living with these debilitating disorders.</description>
     <link>http://medicalxpress.com/news/2012-03-crohn-disease.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Wed, 21 Mar 2012 09:22:39 EST</pubDate>
	 <guid isPermaLink="false">news251540547</guid>
	 
</item>
<item>
     <title>Clinical trials focus on new treatments for Crohn's Disease, dangerous bacterium</title>
   	 <description>Several clinical trials at the University of Cincinnati (UC) are focused on potential treatments for two serious gastroenterological illnesses&amp;#8212;Crohn&amp;#8217;s disease and Clostridium difficile, or C. difficile.</description>
     <link>http://medicalxpress.com/news/2012-03-clinical-trials-focus-treatments-crohn.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 20 Mar 2012 10:04:25 EST</pubDate>
	 <guid isPermaLink="false">news251456546</guid>
	 
</item>
<item>
     <title>Novel therapy for Crohn's disease discovered</title>
   	 <description>The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties.</description>
     <link>http://medicalxpress.com/news/2012-03-therapy-crohn-disease.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Mon, 19 Mar 2012 11:55:48 EST</pubDate>
	 <guid isPermaLink="false">news251376933</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/27-researchersd.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find 5 risk biomarkers for Crohn's disease in Jews of Eastern European descent</title>
   	 <description>In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, also known as Ashkenazi Jews. The findings, which appear in the March 8 online edition of PLoS Genetics, are the first step in an attempt to explain why the prevalence of Crohn's disease is nearly four times higher in Ashkenazi Jews than in other populations.</description>
     <link>http://medicalxpress.com/news/2012-03-genetic-variations-crohn-disease-ashkenazi.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 08 Mar 2012 17:00:08 EST</pubDate>
	 <guid isPermaLink="false">news250444201</guid>
	 
</item>
<item>
     <title>Genetic study sheds new light on auto-immune arthritis</title>
   	 <description>The team of researchers from the Universities of Bristol, Queensland. Oxford, Texas and Toronto, used a technique called genome-wide association where millions of genetic markers are measured in thousands of people that have the disease and thousands of healthy individuals.</description>
     <link>http://medicalxpress.com/news/2011-07-genetic-auto-immune-arthritis.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 10 Jul 2011 13:01:17 EST</pubDate>
	 <guid isPermaLink="false">news229516172</guid>
	 
</item>
<item>
     <title>MR enterography as effective as CT in diagnosing Crohn's disease, reduces radiation exposure</title>
   	 <description>A new study from Rhode Island Hospital has found that MR enterography (MRE) without the use of an anti-peristaltic agent were as reliable as CT enterography (CTE) in determining the presence of Crohn's disease. Additionally, MRE reduces the patient's exposure to ionizing radiation. The study is now published online in advance of print in the European Journal of Radiology.</description>
     <link>http://medicalxpress.com/news/2011-06-enterography-effective-ct-crohn-disease.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 15 Jun 2011 11:04:06 EST</pubDate>
	 <guid isPermaLink="false">news227354347</guid>
	 
</item>
<item>
     <title>Researchers pinpoint role of key proteins in Crohn's Disease</title>
   	 <description>(Medical Xpress) -- Researchers at the University of Toronto have discovered the role the interactions between key proteins plays in the body&amp;#146;s response to Crohn&amp;#146;s Disease - a revelation that may lead to the development of new therapies for patients.</description>
     <link>http://medicalxpress.com/news/2011-06-role-key-proteins-crohn-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 14 Jun 2011 07:45:34 EST</pubDate>
	 <guid isPermaLink="false">news227256286</guid>
	 
</item>
<item>
     <title>Protein from probiotic bacteria may alleviate inflammatory bowel disorders</title>
   	 <description>A protein isolated from beneficial bacteria found in yogurt and dairy products could offer a new, oral therapeutic option for inflammatory bowel disorders (IBD), suggests a study led by Vanderbilt University Medical Center researcher Fang Yan, M.D., Ph.D.</description>
     <link>http://medicalxpress.com/news/2011-05-protein-probiotic-bacteria-alleviate-inflammatory.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 23 May 2011 12:24:53 EST</pubDate>
	 <guid isPermaLink="false">news225372267</guid>
	 
</item>
<item>
     <title>Use of naltrexone reduces inflammation in Crohn's patients</title>
   	 <description>Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.</description>
     <link>http://medicalxpress.com/news/2011-05-naltrexone-inflammation-crohn-patients.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 19 May 2011 09:56:40 EST</pubDate>
	 <guid isPermaLink="false">news225017754</guid>
	 
</item>
<item>
     <title>Duplicating immunity boosting regulatory T-cells to unprecedented levels</title>
   	 <description>University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells &amp;#150; also known as &quot;suppressor cells.&quot; The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods.  Historically, regulatory T-cells have been difficult to replicate.</description>
     <link>http://medicalxpress.com/news/2011-05-duplicating-immunity-boosting-regulatory-t-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 18 May 2011 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224942164</guid>
	 
</item>
<item>
     <title>Adalimumab levels detected in cord blood and infants exposed in utero</title>
   	 <description>Adalimumab (ADA), a drug often prescribed for women with Crohn's disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn's bloodstream for at least three months, researchers at the University of California San Francisco have found.</description>
     <link>http://medicalxpress.com/news/2011-05-adalimumab-cord-blood-infants-exposed.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 08 May 2011 06:26:03 EST</pubDate>
	 <guid isPermaLink="false">news224054725</guid>
	 
</item>


</channel>
</rss>
